文献速递贫血与红细胞疾病

揭示疑似先天性红细胞生成异常性贫血I型的遗传图谱:36例患者回顾性队列研究

Unveiling the genetic landscape of suspected congenital dyserythropoietic anemia type I: A retrospective cohort study of 36 patients.
PubMed 文献 · Am J Hematol · 2024-04-26

该回顾性队列研究纳入36例疑似先天性红细胞生成异常性贫血(CDA)I型患者,89%的病例成功建立分子诊断,其中16例确诊为CDA I,携带CDAN1或CDIN1基因的18个致病变异;另16例获得不同诊断,主要为丙酮酸激酶缺乏症。比较显示CDA I与非CDA I患者在红系形态学特征上无显著差异,但非CDA I患者贫血更重、输血依赖比例更高、促红细胞生成素水平更高。

要点

  • 36例疑似CDA I患者中89%成功建立分子诊断,16例确诊CDA I,携带CDAN1或CDIN1基因的18个致病变异。
  • 非CDA I组贫血更重,重度贫血者中82%为非CDA I vs 18%为CDA I。
  • 非CDA I组输血依赖比例更高(100% vs 41.7%),促红细胞生成素水平显著高于CDA I组。

核心结论

  • 疑似CDA I患者中89%可建立分子诊断,确诊者携带CDAN1或CDIN1致病变异。
  • 非CDA I患者贫血更重、输血依赖比例更高、促红细胞生成素水平更高,但两组红系形态学特征无显著差异。

研究设计与样本

  • 回顾性队列研究,纳入36例疑似先天性红细胞生成异常性贫血I型患者。
  • 对CDIN1变异进行转录组分析。

主要发现

  • 89%的病例成功建立分子诊断,16例确诊CDA I,携带CDAN1或CDIN1基因的18个致病变异。
  • 16例获得不同诊断,主要为丙酮酸激酶缺乏症。
  • CDA I与非CDA I患者红系形态学特征无显著差异,但血红蛋白水平和红细胞计数两组间存在差异,非CDA I患者受影响更严重。
  • 重度贫血患者中82%为非CDA I vs 18%为CDA I;输血依赖比例非CDA I组100% vs CDA I组41.7%。
  • 所有患者骨髓对贫血的反应性均降低,非CDA I患者更明显;非CDA I患者促红细胞生成素水平显著高于CDA I患者; erythroferrone、可溶性转铁蛋白受体和hepcidin血浆浓度两组间无显著差异。

关键数值与推荐

  • 分子诊断建立率89%。
  • CDA I确诊16例,携带CDAN1或CDIN1基因18个致病变异。
  • 非CDA I诊断16例,主要为丙酮酸激酶缺乏症。
  • 重度贫血:非CDA I 82% vs CDA I 18%。
  • 输血依赖:非CDA I 100% vs CDA I 41.7%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Congenital Dyserythropoietic Anemia type I (CDA I) is a rare hereditary condition characterized by macrocytic/normocytic anemia, splenomegaly, iron overload, and distinct abnormalities during late erythropoiesis, particularly internuclear bridges between erythroblasts. Diagnosis of CDA I remains challenging due to its rarity, clinical heterogeneity, and overlapping phenotype with other rare hereditary anemias. In this case series, we present 36 patients with suspected CDA I. A molecular diagnosis was successfully established in 89% of cases, identifying 16 patients with CDA I through the presence of 18 causative variants in the CDAN1 or CDIN1 genes. Transcriptomic analysis of CDIN1 variants revealed impaired erythroid differentiation and disruptions in transcription, cell proliferation, and histone regulation. Conversely, 16 individuals received a different diagnosis, primarily pyruvate kinase deficiency. Comparisons between CDA I and non-CDA I patients revealed no significant differences in erythroblast morphological features. However, hemoglobin levels and red blood cell count differed between the two groups, with non-CDA I subjects being more severely affected. Notably, most patients with severe anemia belonged to the non-CDA I group (82% non-CDA I vs. 18% CDA I), with a subsequent absolute prevalence of transfusion dependency among non-CDA I patients (100% vs. 41.7%). All patients exhibited reduced bone marrow responsiveness to anemia, with a more pronounced effect observed in non-CDA I patients. Erythropoietin levels were significantly higher in non-CDA I patients compared to CDA I patients. However, evaluations of erythroferrone, soluble transferrin receptor, and hepcidin revealed no significant differences in plasma concentration between the two groups.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Marra R, Nostroso A, Rosato BE, et al. Unveiling the genetic landscape of suspected congenital dyserythropoietic anemia type I: A retrospective cohort study of 36 patients. Am J Hematol. 2024. PMID: 38666530. doi:10.1002/ajh.27350

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。